The incidence of pulmonary immune related adverse events in serial [18F]-FDG-PET/CT is not correlated to pulmonary metastasation or intrapulmonary tumor volume but potentially to therapy response in patients treated with immunotherapy
Zeitschriftentitel:
J Nucl Med
Jahr:
2020
Band / Volume:
61 Suppl 1
Print-ISSN:
0161-5505
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)